Skip to main content
×
×
Home

Cholinesterase inhibitors: in search of cholinergic deficits

  • Ross Overshott and Alistair Burns
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cholinesterase inhibitors: in search of cholinergic deficits
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cholinesterase inhibitors: in search of cholinergic deficits
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cholinesterase inhibitors: in search of cholinergic deficits
      Available formats
      ×
Abstract
Copyright
References
Hide All
Brod, M., Stewart, A., Sands, L. et al (1999) Conceptualization and measurement of quality of life in dementia. The Dementia Quality of Life Instrument (DQoL). The Gerontologist, 39, 2535.
Cochrane, M., Cochrane, A., Jauhar, P. et al (2005) Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome – three further cases show response to donepezil. Alcohol Acohol, 40, 151154.
Cole, M. & Primeau, F. (1993) Prognosis of delirium in elderly hospital patients. Canadian Medical Association Journal, 149, 4146.
Dautzenberg, P. L. J., Mulder, L. J., Olde Rikkert, M. G. M. et al (2004) Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage. International Journal of Geriatric Psychiatry, 19, 641644.
Department of Health (2001) National Service Framework for Older People. London: Stationery Office.
Emre, M., Aarsland, D., Albanese, A. et al (2004) Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine, 351, 25092518.
Erkinjuntti, T., Roman, G., Gauthier, S. et al (2004) Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke, 35, 10101017.
McKeith, I., Mintzer, J., Aarsland, D. et al (2004) Dementia with Lewy bodies. Lancet Neurology, 3, 1928.
Moretti, R., Torre, P., Antonello, R.M. et al (2004a) Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. American Journal of Alzheimer's Disease and Other Dementias, 19, 333339.
Moretti, R., Torre, P., Antonello, R. M. et al (2004b) Rivastigmine in frontotemporal dementia: an open-label study. Drugs and Aging, 21, 931937.
National Institute for Clinical Excellence (2001) Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease (Technology Appraisal Guidance no. 19). London: NICE. http://www.nice.org.uk/page.aspx?o=14400
National Institute for Clinical Excellence (2005) Appraisal Consultation Document: Donepezil, Rivastigmine, Galantamine and Memantine for the Treatment of Alzheimer's Disease. http://www.nice.org.uk/page.aspx?o=245908
Petrikis, P., Andreou, C., Piachas, A. et al (2004) Treatment of Huntington's disease with galantamine. International Clinical Psychopharmacology, 19, 4950.
Sano, M., Wilcock, G. K., van Baelen, B. et al (2003) The effects of galantamine treatment on caregiver time in Alzheimer's disease. International Journal of Geriatric Psychiatry, 18, 942950.
Saykin, A., Wishart, H. A., Rabin, L. A. et al (2004) Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain, 127, 15741583.
Zhang, L., Plotkin, R. C., Wang, G. et al (2004) Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives in Physical Medical Rehabilitation, 85, 10501055.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 12 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 21st May 2018. This data will be updated every 24 hours.

Cholinesterase inhibitors: in search of cholinergic deficits

  • Ross Overshott and Alistair Burns
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *